Biermann JS, Adkins D, Benjamin R, Brigman B, Chow W, Conrad EU 3rd, et al. Bone cancer. J Natl Compr Canc Netw. 2007;5(4):420–37.

Article  PubMed  Google Scholar 

Valery PC, Laversanne M, Bray F. Bone cancer incidence by morphological subtype: a global assessment. Cancer Causes Control. 2015;26(8):1127–39.

Article  PubMed  Google Scholar 

Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125(1):229–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kansara M, Teng MW, Smyth MJ, Thomas DM. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14(11):722–35.

Article  CAS  PubMed  Google Scholar 

Kim HJ, Lee SG, Kim YJ, Park JE, Lee KY, Yoo YH, et al. Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells. Int J Oncol. 2013;42(6):1985–92.

Article  CAS  PubMed  Google Scholar 

Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.

Article  PubMed  Google Scholar 

Smrke A, Anderson PM, Gulia A, Gennatas S, Huang PH, Jones RL. Future directions in the treatment of osteosarcoma. Cells. 2021. https://doi.org/10.3390/cells10010172.

Article  PubMed  PubMed Central  Google Scholar 

Daw NC, Chou AJ, Jaffe N, Rao BN, Billups CA, Rodriguez-Galindo C, et al. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer. 2015;112(2):278–82.

Article  CAS  PubMed  Google Scholar 

Yoshikawa K, Ishida M, Yanai H, Tsuta K, Sekimoto M, Sugie T. Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients. PLoS ONE. 2021;16(6):e0253176.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li YC, Zhou Q, Song QK, Wang RB, Lyu S, Guan X, et al. Overexpression of an immune checkpoint (CD155) in breast cancer associated with prognostic significance and exhausted tumor-infiltrating lymphocytes: a cohort study. J Immunol Res. 2020;2020:3948928.

Article  PubMed  PubMed Central  Google Scholar 

Bowers JR, Readler JM, Sharma P, Excoffon K. Poliovirus receptor: more than a simple viral receptor. Virus Res. 2017;242:1–6.

Article  CAS  PubMed  Google Scholar 

Sun Y, Luo J, Chen Y, Cui J, Lei Y, Cui Y, et al. Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma). Int Immunopharmacol. 2020;80:106198.

Article  CAS  PubMed  Google Scholar 

Wu JW, Liu Y, Dai XJ, Liu HM, Zheng YC, Liu HM. CD155 as an emerging target in tumor immunotherapy. Int Immunopharmacol. 2024;131:111896.

Article  CAS  PubMed  Google Scholar 

Li J, Xia Q, Di C, Li C, Si H, Zhou B, et al. Tumor cell-intrinsic CD96 mediates chemoresistance and cancer stemness by regulating mitochondrial fatty acid beta-oxidation. Adv Sci. 2023;10(7):e2202956.

Article  Google Scholar 

Liang J, Liao L, Xie L, Tang W, Yu X, Lu Y, et al. PITPNC1 suppress CD8(+) T cell immune function and promote radioresistance in rectal cancer by modulating FASN/CD155. J Transl Med. 2024;22(1):117.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He W, Zhang H, Han F, Chen X, Lin R, Wang W, et al. CD155T/TIGIT signaling regulates CD8(+) T-cell metabolism and promotes tumor progression in human gastric cancer. Cancer Res. 2017;77(22):6375–88.

Article  CAS  PubMed  Google Scholar 

Zhuo B, Li Y, Gu F, Li Z, Sun Q, Shi Y, et al. Overexpression of CD155 relates to metastasis and invasion in osteosarcoma. Oncol Lett. 2018;15(5):7312–8.

PubMed  PubMed Central  Google Scholar 

Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, et al. Wnt-beta-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(2):121–36.

Article  CAS  PubMed  Google Scholar 

Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmadi Z, Mohammadinejad R, Roomiani S, Afshar EG, Ashrafizadeh M. Biological and therapeutic effects of troxerutin: molecular signaling pathways come into view. J Pharmacopuncture. 2021;24(1):1–13.

Article  PubMed  PubMed Central  Google Scholar 

Bianchi M, Canavesi R, Aprile S, Grosa G, Del Grosso E. Troxerutin, a mixture of O-hydroxyethyl derivatives of the natural flavonoid rutin: chemical stability and analytical aspects. J Pharm Biomed Anal. 2018;150:248–57.

Article  CAS  PubMed  Google Scholar 

Zou CY, Wang J, Shen JN, Huang G, Jin S, Yin JQ, et al. Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases. Acta Pharmacol Sin. 2008;29(3):325–32.

Article  CAS  PubMed  Google Scholar 

Berlin O, Samid D, Donthineni-Rao R, Akeson W, Amiel D, Woods VL Jr. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res. 1993;53(20):4890–5.

CAS  PubMed  Google Scholar 

Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):320–5.

Article  Google Scholar 

Zhao Z, Jia Q, Wu MS, Xie X, Wang Y, Song G, et al. Degalactotigonin, a natural compound from Solanum nigrum L., inhibits growth and metastasis of osteosarcoma through GSK3beta inactivation-mediated repression of the hedgehog/Gli1 pathway. Clin Cancer Res. 2018;24(1):130–44.

Article  CAS  PubMed  Google Scholar 

Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, notch, and hedgehog pathways. Nat Rev Clin Oncol. 2011;8(2):97–106.

Article  CAS  PubMed  Google Scholar 

Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, et al. Targeting notch to target cancer stem cells. Clin Cancer Res. 2010;16(12):3141–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu W, Zhao Z, Wang Y, Li W, Su Q, Jia Q, et al. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/beta-catenin signaling pathway. Cell Death Dis. 2018;9(3):343.

Article  PubMed  PubMed Central  Google Scholar 

Luo X, Li L, Xu W, Cheng Y, Xie Z. HLY78 attenuates neuronal apoptosis via the LRP6/GSK3beta/beta-catenin signaling pathway after subarachnoid hemorrhage in rats. Neurosci Bull. 2020;36(10):1171–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo X, Li L, Zheng W, Gu L, Zhang X, Li Y, et al. HLY78 protects blood-brain barrier integrity through Wnt/beta-catenin signaling pathway following subarachnoid hemorrhage in rats. Brain Res Bull. 2020;162:107–14.

Article  CAS  PubMed  Google Scholar 

Wang S, Yin J, Chen D, Nie F, Song X, Fei C, et al. Small-molecule modulation of Wnt signaling via modulating the Axin-LRP5/6 interaction. Nat Chem Biol. 2013;9(9):579–85.

Article  CAS  PubMed